Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple seed-matched messenger RNA 3' untranslated regions (3'UTRs) refer to the collective set of sequences within the transcriptome that are complementary to the seed region (nucleotides 2-7 or 2-8) of a microRNA (miRNA) or small interfering RNA (siRNA) (Bartel, 2009). These regions serve as the primary docking sites for the RNA-induced silencing complex (RISC), which facilitates post-transcriptional gene silencing through mRNA degradation or translational inhibition (Setten et al., 2019). In therapeutic development, targeting multiple 3'UTRs is a hallmark of miRNA-based drugs, which aim to modulate entire biological pathways rather than single genes. Conversely, unintended binding to multiple seed-matched 3'UTRs is a major source of off-target toxicity in siRNA therapeutics, as a single siRNA can potentially regulate hundreds of transcripts (Grimm, 2009). A specific therapeutic application involves 'Death Induced by Survival gene Elimination' (DISE), where siRNAs are designed to target the 3'UTRs of multiple essential survival genes simultaneously to kill cancer cells (Putzbach et al., 2017). This mechanism is also central to the function of endogenous miRNAs, which maintain cellular homeostasis by fine-tuning the expression of large gene networks. Drugs interacting with these sites include various siRNA and miRNA-based therapeutics currently in clinical use or development, such as Patisiran and Givosiran. Safety concerns primarily involve the potential for widespread off-target effects and the saturation of endogenous RNA processing pathways.
RNA interference (RNAi) and microRNA-mediated gene silencing via binding to complementary seed sequences in the 3'UTR of target mRNAs, leading to mRNA cleavage or translational repression.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple seed-matched messenger RNA 3' untranslated regions (mRNA 3'UTR seed-match sites).